Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | 5' AMP activated protein kinase subunit beta 1 | 0.003 | 0.0236 | 0.0236 |
Loa Loa (eye worm) | CAMK/CAMKL/AMPK protein kinase | 0.0116 | 0.2986 | 0.2986 |
Leishmania major | hypothetical protein, conserved | 0.0055 | 0.1052 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Loa Loa (eye worm) | 5'-AMP-activated protein kinase | 0.0055 | 0.1052 | 0.1052 |
Schistosoma mansoni | protein kinase subunit beta | 0.003 | 0.0236 | 0.0236 |
Echinococcus granulosus | AMPK beta subunit | 0.0055 | 0.1052 | 0.1052 |
Plasmodium falciparum | serine/threonine protein kinase KIN | 0.0022 | 0 | 0.5 |
Plasmodium vivax | serine/threonine protein kinase KIN, putative | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Brugia malayi | 5'-AMP-activated protein kinase, beta subunit, complex-interacting region containing protein | 0.0055 | 0.1052 | 0.1052 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Echinococcus granulosus | 5' AMP activated protein kinase catalytic | 0.0116 | 0.2986 | 0.2986 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Trypanosoma cruzi | 5'-AMP-activated protein kinase subunit beta, putative | 0.0055 | 0.1052 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Giardia lamblia | 5-AMP-activated protein kinase, gamma-1 subunit | 0.0336 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Trypanosoma cruzi | SNF1-related protein kinase regulatory subunit beta, putative | 0.0055 | 0.1052 | 1 |
Onchocerca volvulus | Alicorn homolog | 0.0048 | 0.083 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0116 | 0.2986 | 0.2986 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0022 | 0 | 0.5 |
Echinococcus granulosus | 5' AMP activated protein kinase subunit gamma | 0.0336 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Brugia malayi | 5'-AMP-activated protein kinase, beta subunit, complex-interacting region containing protein | 0.0055 | 0.1052 | 0.1052 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Echinococcus granulosus | 5' AMP activated protein kinase subunit beta 1 | 0.003 | 0.0236 | 0.0236 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Echinococcus multilocularis | AMPK beta subunit | 0.0055 | 0.1052 | 0.1052 |
Echinococcus multilocularis | 5' AMP activated protein kinase subunit gamma | 0.0336 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Toxoplasma gondii | 5'-AMP-activated protein kinase subunit beta-1 family protein, putative | 0.0033 | 0.033 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Schistosoma mansoni | protein kinase subunit gamma | 0.0336 | 1 | 1 |
Echinococcus multilocularis | 5' AMP activated protein kinase subunit gamma | 0.0315 | 0.9337 | 0.9337 |
Brugia malayi | EST embl|AI107989|AI107989 comes from the 3' UTR, putative | 0.0116 | 0.2986 | 0.2986 |
Loa Loa (eye worm) | loechrig isoform VII | 0.0336 | 1 | 1 |
Giardia lamblia | 5-AMP-activated protein kinase, beta-1 subunit | 0.0055 | 0.1052 | 0.1052 |
Echinococcus multilocularis | 5' AMP activated protein kinase catalytic | 0.0116 | 0.2986 | 0.2986 |
Schistosoma mansoni | protein kinase subunit beta | 0.0055 | 0.1052 | 0.1052 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0022 | 0 | 0.5 |
Trypanosoma brucei | 5'-AMP-activated protein kinase subunit beta | 0.0055 | 0.1052 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.